GlassScriptPhysician profile
Scott Norris
NPI 1023671559
$5,785.99
in general payments reported to CMS, 2019-2025
10 companies · $2,953 in 2025
The $2,953 reported for 2025 was more than what 89% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $474 · 2023: $1,575 · 2024: $785 · 2025: $2,953.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,202 · Travel and Lodging: $2,110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,202.45 |
| Travel and Lodging | $2,109.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $4,942.37 | 2022-2025 | Pico, Versajet, Collagenase Santyl |
| Stryker Corporation | $322.13 | 2022-2025 | Citrefix |
| W. L. Gore & Associates, INC. | $143.11 | 2022 | |
| Lifenet Health | $102.99 | 2023-2025 | Theragenesis Wound Matrix |
| Treace Medical Concepts, INC. | $77.29 | 2023-2025 | |
| Kerecis Limited | $68.05 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $36.88 | 2023-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $34.38 | 2023 | Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $32.43 | 2024-2025 | Nushield |
| Depuy Synthes Sales INC. | $26.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Norris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.